Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 16;9(5):00214-2023.
doi: 10.1183/23120541.00214-2023. eCollection 2023 Sep.

Octane in exhaled breath to diagnose acute respiratory distress syndrome in invasively ventilated intensive care unit patients

Affiliations

Octane in exhaled breath to diagnose acute respiratory distress syndrome in invasively ventilated intensive care unit patients

Laura A Hagens et al. ERJ Open Res. .

Abstract

Background: The concentration of exhaled octane has been postulated as a reliable biomarker for acute respiratory distress syndrome (ARDS) using metabolomics analysis with gas chromatography and mass spectrometry (GC-MS). A point-of-care (POC) breath test was developed in recent years to accurately measure octane at the bedside. The aim of the present study was to validate the diagnostic accuracy of exhaled octane for ARDS using a POC breath test in invasively ventilated intensive care unit (ICU) patients.

Methods: This was an observational cohort study of consecutive patients receiving invasive ventilation for at least 24 h, recruited in two university ICUs. GC-MS and POC breath tests were used to quantify the exhaled octane concentration. ARDS was assessed by three experts following the Berlin definition and used as the reference standard. The area under the receiver operating characteristic curve (AUC) was used to assess diagnostic accuracy.

Results: 519 patients were included and 190 (37%) fulfilled the criteria for ARDS. The median (interquartile range) concentration of octane using the POC breath test was not significantly different between patients with ARDS (0.14 (0.05-0.37) ppb) and without ARDS (0.11 (0.06-0.26) ppb; p=0.64). The AUC for ARDS based on the octane concentration in exhaled breath using the POC breath test was 0.52 (95% CI 0.46-0.57). Analysis of exhaled octane with GC-MS showed similar results.

Conclusions: Octane in exhaled breath has insufficient diagnostic accuracy for ARDS. This disqualifies the use of octane as a biomarker in the diagnosis of ARDS and challenges most of the research performed up to now in the field of exhaled breath metabolomics.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: L.D.J. Bos reports grants from the Dutch Lung Foundation (Young Investigator grant and Dirkje Postma Award), the Dutch Lung Foundation and Health Holland (public–private partnership grant), and the IMI COVID19 initiative, and an Amsterdam UMC fellowship, a ZonMW COVID-19 Urgency grant and the ERS Gold Metal for ARDS; he reports participating in advisory boards for Sobi, Exvastat, Santhera, Pfizer and AstraZeneca, all paid to his institution, and consultancy for Scailyte, Santhera and Janssen & Janssen, all paid to his institution, outside the submitted work. A.R.M. Verschueren, T.M.E. Nijsen, I. Geven, C.N. Presură and R. Rietman are employees of Philips Research. L.A. Hagens, N.F.L. Heijnen, M.R. Smit, D.W. Fenn, P. Brinkman, M.J. Schultz, D.C.J.J. Bergmans and R.M. Schnabel have no conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
Study flowchart. MV: mechanical ventilation; ARDS: acute respiratory distress syndrome; GC-MS: gas chromatography-mass spectrometry; POC: point-of-care.
FIGURE 2
FIGURE 2
Exhaled breath octane concentration (log10 scale) compared between patients with and without acute respiratory distress syndrome (ARDS) measured with the point-of-care (POC) breath test and gas chromatography-mass spectrometry (GC-MS) displayed stratified for ARDS (certain “ARDS” and “likely ARDS” versus certain “no ARDS” and “likely no ARDS”, dichotomised). There was no significant difference in breath octane concentration between patients with and without ARDS for the POC breath test (p=0.64) or GC-MS (p=0.75).
FIGURE 3
FIGURE 3
Area under the receiver operating characteristic curve (AUC) describing the diagnostic accuracy for acute respiratory distress syndrome of the octane concentration measured with a) point-of-care (POC) breath test and Lung Injury Prediction Score (LIPS) and b) gas chromatography-mass spectrometry (GC-MS) and LIPS.
FIGURE 4
FIGURE 4
Longitudinal sampling. Octane concentrations (log10 scale) as measured with the point-of-care breath test. Time-points 1 and 2: both the acute respiratory distress syndrome (ARDS) and no ARDS groups. Time-points 3–5: only ARDS patients. Time-point 3 corresponds to day 3 after inclusion, time-point 4 to day 5 and time-point 5 to day 12. p-values compared with time-point 1: time-point 2: p=0.30; time-point 3: p=0.55; time-point 4: p=0.10; time-point 5: p=0.07.

References

    1. Mac Sweeney R, McAuley DF. Acute respiratory distress syndrome. Lancet 2016; 388: 2416–2430. doi: 10.1016/S0140-6736(16)00578-X - DOI - PMC - PubMed
    1. Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315: 788–800. doi: 10.1001/jama.2016.0291 - DOI - PubMed
    1. ARDS Definition Task Force . Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526–2533. doi: 10.1001/jama.2012.5669 - DOI - PubMed
    1. Bellani G, Pham T, Laffey JG. Missed or delayed diagnosis of ARDS: a common and serious problem. Intensive Care Med 2020; 46: 1180–1183. doi: 10.1007/s00134-020-06035-0 - DOI - PMC - PubMed
    1. Binnie A, Tsang JLY, dos Santos CC. Biomarkers in acute respiratory distress syndrome. Curr Opin Crit Care 2014; 20: 47–55. doi: 10.1097/MCC.0000000000000048 - DOI - PubMed

LinkOut - more resources